Stada Strikes Deals With Lobsor And MediPharm
Lobsor Offers Value-Added Parkinson's Disease Treatment; MediPharm Adds Cannabis
Executive Summary
Stada's Britannia Pharmaceuticals has acquired Sweden's Lobsor and its Lecigon gel formulation which is already approved in the Nordics and combines levodopa, carbidopa and entacapone infused via a lightweight pump. Meanwhile, Stada has also formed an alliance with MediPharm Labs for medical cannabis.